Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Opioids
Sort By
Newest First
1 / 2
Opioids
Analysis of Government Data Reveals Main Players in Opioid Market
Emilie Branch
Pharma's Almanac
PAO-M08-19-NI-013
Aug 07, 2019
Opioids
Statement on FDA’s Request for Information on Requiring Fixed-Quantity Blister Packaging for Certain Opioid Pain Medicines
PR-M06-19-NI-003
Jun 05, 2019
Opioids
Top Execs at Opioid Maker Insys Therapeutics Found Guilty of Paying Bribes
Nice Insight
PAO-M05-19-NI-015
May 10, 2019
Heron Therapeutics, Inc.
Partnership
Heron Therapeutics Partners with the National Academy of Medicine to Counter the Opioid Epidemic in the United States
Heron Therapeutics, Inc.
PR-M05-19-NI-027
May 09, 2019
U.S. Food & Drug Administration
FDA Statement
FDA Statement on New Opioid Analgesic Labeling Changes
U.S. Food & Drug Administration
PR-M04-19-NI-042
Apr 12, 2019
Opioids
Generic Suboxone Sublingual Film Launched
Emilie Branch
Pharma's Almanac
PAO-M03-19-NI-004
Mar 05, 2019
U.S. Food & Drug Administration
Opioids
Statement from FDA Commissioner Scott Gottlieb, M.D. on the Agency's 2019 policy and Regulatory Agenda for Continued Action to Forcefully Address Opioid Abuse
U.S. Food & Drug Administration
PR-M02-19-NI-061
Feb 27, 2019
U.S. Food & Drug Administration
FDA Statement
Statement from FDA Commissioner Scott Gottlieb, M.D., on Ongoing Efforts to Secure the U.S. Supply Chain and Confront the Opioid Epidemic
U.S. Food & Drug Administration
PR-M02-19-NI-032
Feb 14, 2019
NYU Langone Health
Opioids
New Study Shows Physician-Targeted Marketing is Associated with Increase in Opioid Overdose Deaths
NYU Langone Health
PR-M01-19-NI-063
Jan 22, 2019
Opioid Dependency
Could the Opioid Epidemic Be Relieved by a Vaccine?
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M12-18-NI-019
Dec 19, 2018
U.S. Food & Drug Administration
FDA Statement
Statement from FDA Commissioner Scott Gottlieb, M.D., on Agency's Approval of Dsuvia and the FDA's Future Consideration of New Opioids
U.S. Food & Drug Administration
PR-M11-18-NI-016
Nov 05, 2018
HBI Solutions
Opioids
HBI Solutions' Tool Predicts Who Is Likely to Abuse Opioids Using Medical and Social Data
HBI Solutions
PR-M07-18-NI-064
Jul 19, 2018
Opioids
Gottlieb Discusses Results of Online Opioid Summit
Emilie Branch
Pharma's Almanac
PAO-M07-18-NI-003
Jul 10, 2018
Opiods
Preliminary Data Suggests DENKI Pain Blockers Don’t Have Abuse Potential
Emilie Branch
Pharma's Almanac
PAO-M06-18-NI-008
Jun 12, 2018
Abuse Deterrence
Generic Firms Developing Opioids with Abuse-Deterrent Properties Have New FDA Guidance to Follow
Emilie Branch
Pharma's Almanac
PAO-M12-17-NI-012
Dec 08, 2017
Innovation
Study Reveals New Medication Options for Opioid Dependency
Nice Insight
PAO-M11-17-NI-040
Nov 23, 2017
Non-Opioid
SiteOne Therapeutics Garners US Department of Defense Award
Emilie Branch
Pharma's Almanac
PAO-M11-17-NI-036
Nov 21, 2017
Information Technology
Fighting Opioid Abuse, Axial Healthcare Rolls Out New IT-based Care Platform
Guy Tiene
Nice Insight
PAO-M10-17-NI-034
Oct 24, 2017
Abuse Deterrence
Fighting Prescription Drug Abuse with Demonstrated Abuse-Deterrent Formulations
Angela Moore, M.Sc.
Alcami
PAP-Q3-17-CL-003
Sep 15, 2017
Drug Development
Novel Genetic Test Helps Confirm Opioid Addiction Risk
Emilie Branch
Pharma's Almanac
PAO-M09-17-NI-006
Sep 05, 2017
1 / 2
